Provided by Tiger Fintech (Singapore) Pte. Ltd.

Elanco Animal Health Inc

17.84
-0.5150-2.81%
Volume:4.43M
Turnover:79.46M
Market Cap:8.86B
PE:20.38
High:18.12
Open:18.08
Low:17.79
Close:18.35
52wk High:18.87
52wk Low:8.02
Shares:496.81M
Float Shares:492.94M
Volume Ratio:0.23
T/O Rate:0.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.8753
EPS(LYR):0.6842
ROE:6.83%
ROA:0.98%
PB:1.31
PE(LYR):26.07

Loading ...

Company Profile

Company Name:
Elanco Animal Health Inc
Exchange:
NYSE
Establishment Date:
1954
Employees:
9225
Office Location:
2500 Innovation Way,Greenfield,Indiana,United States
Zip Code:
46140
Fax:
- -
Introduction:
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.

Directors

Name
Position
Jeffrey N. Simmons
President, Chief Executive Officer and Director
Lawrence E. Kurzius
Chairman of the Board
Art A. Garcia
Independent Director
Deborah T. Kochevar
Independent Director
Denise Scots Knight
Independent Director
Kapila K. Anand
Independent Director
Kirk P. McDonald
Independent Director
Michael J. Harrington
Independent Director
Paul S. Herendeen
Independent Director
R. David Hoover
Independent Director
Stacey Ma
Independent Director

Shareholders

Name
Position
Jeffrey N. Simmons
President, Chief Executive Officer and Director
James M. Meer
Senior Vice President and Chief Accounting Officer
Robert M. VanHimbergen
Executive Vice President and Chief Financial Officer
David S. Kinard
Executive Vice President, Human Resources, Corporate Communications and Administration
Ellen de Brabander
Executive Vice President, Innovation and Regulatory Affairs
Grace McArdle
Executive Vice President, Manufacturing and Quality
Jose Manuel Correia de Simas
Executive Vice President, U.S. Farm Animal Business
Rajeev A. Modi
Executive Vice President, U.S. Pet Health and Global Digital Transformation
Ramiro M. Cabral
Executive Vice President and President of Elanco International
Shiv O'Neill
Executive Vice President, General Counsel and Corporate Secretary
Timothy J. Bettington
Executive Vice President, Corporate Strategy and Market Development